Craig T, Feuersenger H, Pragst I, Dang J, et al. Prophylactic therapy with subcutaneous C1-inhibitor is associated with sustained symptom control in patients with hereditary angioedema. Allergy Asthma Proc 2022;43:202-208.
PMID: 35524357